Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non‐inferiority, phase III trial

Background and Aim Remimazolam tosilate (RT) is a new short‐acting GABA(A) receptor agonist, having potential to be an effective option for procedural sedation. Here, we aimed to compare the efficacy and safety of RT with propofol in patients undergoing upper gastrointestinal endoscopy. Methods This...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of gastroenterology and hepatology Vol. 36; no. 2; pp. 474 - 481
Main Authors:	Chen, Shao‐Hui, Yuan, Tang‐Mi, Zhang, Jiao, Bai, Hua, Tian, Ming, Pan, Chu‐Xiong, Bao, Hong‐Guang, Jin, Xiao‐Ju, Ji, Fu‐Hai, Zhong, Tai‐Di, Wang, Qiang, Lv, Jian‐Rui, Wang, Sheng, Li, Yu‐Juan, Yu, Yong‐Hao, Luo, Ai‐Lin, Li, Xiang‐Kui, Min, Su, Li, Lin, Zou, Xiao‐Hua, Huang, Yu‐Guang
Format:	Journal Article
Language:	English
Published:	Australia Wiley Subscription Services, Inc 01.02.2021
Subjects:	Adverse events Anesthesia benzodiazepine endoscopic sedation Endoscopy GABA (A) receptor agonist Hypotension Propofol remimazolam remimazolam tosilate Safety Success upper gastrointestinal endoscopy γ-Aminobutyric acid GABA (A) receptor agonist remimazolam remimazolam tosilate endoscopic sedation upper gastrointestinal endoscopy benzodiazepine
ISSN:	0815-9319, 1440-1746, 1440-1746
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!